SCHEMBL4384032

SCHEMBL4384032

O=C(O)C1CCCC1C(=O)Cc1ccccc1

nearest known ligand 0.53

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
TAAR1 Q96RJ0 2/20 0.53
FAAH O00519 1/20 0.51
PEPD P12955 1/20 0.50
ALDH1A1 P00352 2/20 0.49
HPGD P15428 2/20 0.49
GLA P06280 1/20 0.49
EPHX2 P34913 1/20 0.47
CES2 O00748 1/20 0.45
CES1 P23141 1/20 0.45
AKR1B1 P15121 1/20 0.45
L3MBTL1 Q9Y468 1/20 0.45
RAB9A P51151 2/20 0.45
MEN1 O00255 1/20 0.44
KMT2A Q03164 1/20 0.44
HDAC8 Q9BY41 1/20 0.44
HDAC6 Q9UBN7 1/20 0.44
USP2 O75604 1/20 0.44
LMNA P02545 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18440290 0.82 SLC6A2 (0.48) FAAHALDH1A1HPGDGLAEPHX2
SCHEMBL16617332 0.81 MEN1 (0.47) TAAR1PEPDALDH1A1HPGDL3MBTL1
SCHEMBL4656202 0.79 ALDH1A1 (0.56) FAAHALDH1A1HPGDGLAEPHX2
SCHEMBL1028000 0.77 ALDH1A1 (0.44) FAAHALDH1A1HPGDGLAEPHX2
SCHEMBL800064 0.76 EPHX2 (0.56) FAAHALDH1A1HPGDGLAEPHX2
SCHEMBL1155730 0.75 FAAH (0.55) FAAHALDH1A1HPGDGLAEPHX2
SCHEMBL595790 0.75 TSHR (0.55) TAAR1ALDH1A1L3MBTL1RAB9AKMT2A
SCHEMBL596126 0.75 TSHR (0.55) TAAR1ALDH1A1L3MBTL1RAB9AKMT2A
SCHEMBL14324086 0.75 TSHR (0.55) TAAR1ALDH1A1L3MBTL1RAB9AKMT2A
SCHEMBL595759 0.75 TSHR (0.55) TAAR1ALDH1A1L3MBTL1RAB9AKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7629340-B2 N-(6-membered aromatic ring)-amido anti-viral compounds SMITHKLINE BEECHAM CORPORATION (US) 2009-12-08 US disclosed
US-20070265262-A1 N-(6-MEMBERED AROMATIC RING)-AMIDO ANTI-VIRAL COMPOUNDS GENELABS TECHNOLOGIES, INC. 2007-11-15 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070265262-A1 N-(6-MEMBERED AROMATIC RING)-AMIDO ANTI-VIRAL COMPOUNDS ZC3HAV1, HAVCR2, ZC3HAV1L TAAR1 1821/4885FAAH 1739/4885PEPD 1503/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.